These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 6127401)
1. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist. Hahn RA; Wardell JR; Sarau HM; Ridley PT J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog. Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644 [TBL] [Abstract][Full Text] [Related]
3. SK&F 87516, a close analog of fenoldopam, is a partial agonist at dopamine-1 and alpha-2 receptors and produces stimulation of 5-hydroxytryptamine-2 receptors in the cardiovascular system of the rat. Le Monnier de Gouville AC; Lawson K; Thiry C; Cavero I J Pharmacol Exp Ther; 1991 Mar; 256(3):1049-56. PubMed ID: 1672375 [TBL] [Abstract][Full Text] [Related]
4. Further characterization of the cardiovascular effects of the dopamine beta-hydroxylase inhibitor SK&F 102698 in conscious hypertensive rats. Ohlstein EH; Kruse LI; Ezekiel M; Willette RN J Pharmacol Exp Ther; 1988 Oct; 247(1):186-95. PubMed ID: 3050029 [TBL] [Abstract][Full Text] [Related]
6. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog. Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR Chirality; 1990; 2(4):219-25. PubMed ID: 1982058 [TBL] [Abstract][Full Text] [Related]
8. Suppression of sympathetic ganglionic neurotransmission by the selective dopamine-1 receptor agonist fenoldopam (SK&F 82526) in the anesthetized dog. Shebuski RJ; Fujita T; Smith JM; Kopaciewicz LJ; Blumberg AL; Hieble JP J Pharmacol Exp Ther; 1985 Dec; 235(3):735-40. PubMed ID: 2867207 [TBL] [Abstract][Full Text] [Related]
9. Potential usefulness of renal vasodilators in hypertension and renal disease: SK&F 82526. Ackerman DM; Blumberg AL; McCafferty JP; Sherman SS; Weinstock J; Kaiser C; Berkowitz B Fed Proc; 1983 Feb; 42(2):186-90. PubMed ID: 6130004 [TBL] [Abstract][Full Text] [Related]
10. Systemic, pulmonary and coronary haemodynamic actions of the novel dopamine receptor agonist in awake pigs at rest and during treadmill exercise Z1046. Duncker DJ; Haitsma DB; van der Geest IE; Stubenitsky R; van Meegen JR; Man in't Veld AJ; Verdouw PD Br J Pharmacol; 1997 Mar; 120(6):1101-13. PubMed ID: 9134223 [TBL] [Abstract][Full Text] [Related]
11. Effects of cerebroventricular administration of ouabain on renal hemodynamics in anesthetized dogs: evidence for the participation of renal dopaminergic vasodilator fibers. Hom GJ; Jandhyala BS J Pharmacol Exp Ther; 1984 Aug; 230(2):275-83. PubMed ID: 6747837 [TBL] [Abstract][Full Text] [Related]
13. Studies on vascular dopamine receptors with the dopamine receptor agonist: SK&F 82526. Ohlstein EH; Zabko-Potapovich B; Berkowitz BA J Pharmacol Exp Ther; 1984 May; 229(2):433-9. PubMed ID: 6143817 [TBL] [Abstract][Full Text] [Related]
14. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers. Kinter LB; Mann WA; Weinstock J; Ruffolo RR Chirality; 1994; 6(5):446-55. PubMed ID: 7915128 [TBL] [Abstract][Full Text] [Related]
15. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822. Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023 [TBL] [Abstract][Full Text] [Related]
16. Analysis of the effects of dopamine-1 and dopamine-2 receptor agonists on coronary flow. Zhao RR; Wang PH; Zhang WF; Fennell WH Methods Find Exp Clin Pharmacol; 1992; 14(1):5-11. PubMed ID: 1352371 [TBL] [Abstract][Full Text] [Related]
17. Effects of SK&F 82526 and SK&F 83742 on the renal vascular dopamine receptor. Schmidt M; Imbs JL; Giesen-Crouse EM; Schwartz J J Pharmacol; 1985; 16(1):15-22. PubMed ID: 2582206 [TBL] [Abstract][Full Text] [Related]
18. Hypotensive and regional hemodynamic effects of the dopamine receptor agonist SK & F 85174 in the anesthetized rat. Van der Niepen P; Schoors DF; Dupont AG Arch Int Pharmacodyn Ther; 1991; 313():98-107. PubMed ID: 1687774 [TBL] [Abstract][Full Text] [Related]
19. The cardiovascular actions of dopamine and the effects of central and peripheral catecholaminergic receptor blocking drugs. Setler PE; Pendleton RG; Finlay E J Pharmacol Exp Ther; 1975 Mar; 192(3):702-12. PubMed ID: 1120964 [TBL] [Abstract][Full Text] [Related]
20. Effects of dopamine on renal haemodynamics tubular function and sodium excretion in normal humans. Olsen NV Dan Med Bull; 1998 Jun; 45(3):282-97. PubMed ID: 9675540 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]